Désolé, cet article est seulement disponible en anglais américain.
Cliquez pour voir le graph
Connexions
Présentation
Membres
Michael White
Responsable de Structure
Responsable
Projets
Projet Transversal
Publications
Télécharger-
2024Evaluating vector competence for Yellow fever in the Caribbean., Nat Commun 2024 Feb; 15(1): 1236.
-
2024PvDBPII elicits multiple antibody-mediated mechanisms that reduce growth in a Plasmodium vivax challenge trial., NPJ Vaccines 2024 Jan; 9(1): 10.
-
2023Accelerating towards P. vivax elimination with a novel serological test-and-treat strategy: a modelling case study in Brazil., Lancet Reg Health Am 2023 Jun; 22(): 100511.
-
2023Estimated protection against COVID-19 based on predicted neutralisation titres from multiple antibody measurements in a longitudinal cohort, France, April 2020 to November 2021., Euro Surveill 2023 Jun; 28(25): .
-
2023Divergent adaptive immune responses define two types of long COVID., Front Immunol 2023 ; 14(): 1221961.
-
2022Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study., EClinicalMedicine 2022 Sep; 51(): 101576.
-
2022Zika vector competence data reveals risks of outbreaks: the contribution of the European ZIKAlliance project., Nat Commun 2022 Aug; 13(1): 4490.
-
2022Kinetics of the SARS-CoV-2 Antibody Avidity Response Following Infection and Vaccination., Viruses 2022 07; 14(7): .
-
2022Developing sero-diagnostic tests to facilitate Plasmodium vivax Serological Test-and-Treat approaches: modeling the balance between public health impact and overtreatment., BMC Med 2022 03; 20(1): 98.
-
2021How radical is radical cure? Site-specific biases in clinical trials underestimate the effect of radical cure on Plasmodium vivax hypnozoites., Malar J 2021 Dec; 20(1): 479.
-
+Voir la liste complète de publications